ADARx Pharmaceuticals CEO Zhen Li found her way to biopharma through Merck, where she was inspired by the application of ...

At the heart of equitable healthcare lies a critical truth: representation matters.  BlackDoctor.org spoke with Dr. Adrelia ...

The stock's rise snapped a three-day losing streak.

Despite weakness in these two blue chip stocks, the Dow Jones Industrial Average managed to add 0.4% to 44,502 thanks to ...

Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial ...

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

Commerce Secretary Howard Lutnick said Trump's new tariff policies are focused on ending the U.S.'s reliance on foreign supply of key pharmaceutical products. "We are proud that AstraZeneca has made ...

The U.K. biopharmaceutical giant’s plans include a proposal for a new drug substance manufacturing center focused on ...

In June 2025, the FDA approved KEYTRUDA for perioperative use in adults with resectable, locally advanced head and neck ...

The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...

Eckhardt served as head of legal, overseeing M&A, ventures, and finance at the DAX-listed healthcare company based in ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...